These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 49077)

  • 21. Macrophages suppress direct B-cell activation by lipopolysaccharide.
    Lemke H; Coutinho A; Opitz HG; Gronowicz E
    Scand J Immunol; 1975; 4(7):707-20. PubMed ID: 1081735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carrier-directed anti-hapten responses by B-cell subsets.
    Lewis GK; Goodman JW
    J Exp Med; 1977 Jul; 146(1):1-10. PubMed ID: 68986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A reappraisal of "T-independent" antigens. II. Studies on single, hapten-specific B cells from neonatal CBA/H or CBA/N mice fail to support classification into TI-1 and TI-2 categories.
    Nossal GJ; Pike BL
    J Immunol; 1984 Apr; 132(4):1696-701. PubMed ID: 6199408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant effect of bacterial LPS and/or alum precipitation in responses to polysaccharide and protein antigens.
    Seppälä IJ; Mäkelä O
    Immunology; 1984 Dec; 53(4):827-36. PubMed ID: 6209209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen.
    Möller G; Gronowicz E; Persson U; Coutinho A; Möller E; Hammarström L; Smith E
    J Exp Med; 1976 Jun; 143(6):1429-38. PubMed ID: 775013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen-induced aggregation and modulation of receptors on hapten-specific B lymphocytes.
    Nossal GJ; Layton JE
    J Exp Med; 1976 Mar; 143(3):511-28. PubMed ID: 55458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The polyclonal B-cell-activating property of protein A is not due to its interaction with the FC part of immunoglobulin receptors.
    Möller G; Landwall P
    Scand J Immunol; 1977; 6(4):357-66. PubMed ID: 323965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetical control of B-cell responses. III. Requirement for functional mitogenicity of the antigen in thymus-independent specific responses.
    Coutinho A; Gronowicz E
    J Exp Med; 1975 Apr; 141(4):753-60. PubMed ID: 1092788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune response against two epitopes on the same thymus-independent polysaccharide carrier. 1. Role of epitope density in carrier-dependent immunity and tolerance.
    Fernandez C; Möller G
    Immunology; 1977 Jul; 33(1):59-68. PubMed ID: 68926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two signals are required for accessory cells to induce B cell unresponsiveness. Tolerogenic Ig and prostaglandin.
    Schad VC; Phipps RP
    J Immunol; 1988 Jul; 141(1):79-84. PubMed ID: 2454266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of immunological tolerance requires that the B cells can respond to the polyclonal B-cell-activating properties of the thymus-independent antigens.
    Fernandez C; Möller G
    J Exp Med; 1977 Jul; 146(1):308-12. PubMed ID: 68993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary antibody responses to hapten-modified syngeneic cells: exceptional immunogenicity of erythrocytes.
    Nakashima I; Takashi M; Nagase F; Kato N
    Eur J Immunol; 1981 Nov; 11(11):946-8. PubMed ID: 6799301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hapten-specific murine colony-forming B cells: in vitro response of colonies to fluoresceinated thymus independent antigens.
    Pillai PS; Scott DW
    J Immunol; 1981 May; 126(5):1883-6. PubMed ID: 6163821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyclonal B cell responses in the presence of defined filler cells: complementary effects of lipopolysaccharide and anti-immunoglobulin antibodies.
    Zubler RH
    Eur J Immunol; 1984 Apr; 14(4):357-63. PubMed ID: 6233156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of C'3 and Fc receptors in B-lymphocyte activation.
    Möller G; Coutinho A
    J Exp Med; 1975 Mar; 141(3):647-63. PubMed ID: 1090702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
    Friedman H; Kateley JR
    Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperativity between B lymphocyte membrane molecules: independent ligand occupancy and cross-linking of antigen receptors and Fc gamma receptors down-regulates B lymphocyte function.
    Uher F; Dickler HB
    J Immunol; 1986 Nov; 137(10):3124-9. PubMed ID: 2945858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The induction of hapten-specific immunological tolerance and immunity in B lymphocytes. VI. Differential tolerance susceptibility in adult spleen as a function of B-cell maturation level.
    Fidler JM
    J Exp Med; 1979 Sep; 150(3):491-506. PubMed ID: 158060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A chemical approach to the mechanism of B-lymphocyte activation. II. The pure presentation of haptens does not inactivate B lymphocytes.
    Vidal-Gomez J
    Scand J Immunol; 1978; 8(4):323-31. PubMed ID: 309627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms by which hapten conjugates of pneumococcal polysaccharide interfere with the challenge of anti-hapten memory cells.
    Romano TJ; Lerman SP; Thorbecke GJ
    Eur J Immunol; 1976 Jun; 6(6):434-42. PubMed ID: 11101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.